Chronic Idiopathic Constipation Drugs Market

List of Tables
Table 1. Chronic Idiopathic Constipation (CIC) Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Chronic Idiopathic Constipation (CIC) Drugs Market Trends
Table 3. Chronic Idiopathic Constipation (CIC) Drugs Market Drivers
Table 4. Chronic Idiopathic Constipation (CIC) Drugs Market Challenges
Table 5. Chronic Idiopathic Constipation (CIC) Drugs Market Restraints
Table 6. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Chronic Idiopathic Constipation (CIC) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Chronic Idiopathic Constipation (CIC) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Chronic Idiopathic Constipation (CIC) Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Chronic Idiopathic Constipation (CIC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation (CIC) Drugs as of 2021)
Table 18. Top Players of Chronic Idiopathic Constipation (CIC) Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type
Table 20. Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Chronic Idiopathic Constipation (CIC) Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Chronic Idiopathic Constipation (CIC) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Chronic Idiopathic Constipation (CIC) Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Actavis Corporation Information
Table 43. Actavis Description and Business Overview
Table 44. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product
Table 46. Actavis Recent Development
Table 47. Chugai Pharmaceutical Corporation Information
Table 48. Chugai Pharmaceutical Description and Business Overview
Table 49. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Chugai Pharmaceutical Product
Table 51. Chugai Pharmaceutical Recent Development
Table 52. Ferring International Center Corporation Information
Table 53. Ferring International Center Description and Business Overview
Table 54. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Ferring International Center Product
Table 56. Ferring International Center Recent Development
Table 57. Synergy Pharmaceuticals Corporation Information
Table 58. Synergy Pharmaceuticals Description and Business Overview
Table 59. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Synergy Pharmaceuticals Product
Table 61. Synergy Pharmaceuticals Recent Development
Table 62. Pfizer Corporation Information
Table 63. Pfizer Description and Business Overview
Table 64. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Pfizer Product
Table 66. Pfizer Recent Development
Table 67. GlaxoSmithKline Corporation Information
Table 68. GlaxoSmithKline Description and Business Overview
Table 69. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. GlaxoSmithKline Product
Table 71. GlaxoSmithKline Recent Development
Table 72. Roche Holding Corporation Information
Table 73. Roche Holding Description and Business Overview
Table 74. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Roche Holding Product
Table 76. Roche Holding Recent Development
Table 77. Sanofi Corporation Information
Table 78. Sanofi Description and Business Overview
Table 79. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Sanofi Product
Table 81. Sanofi Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. Salix Pharmaceuticals Corporation Information
Table 88. Salix Pharmaceuticals Description and Business Overview
Table 89. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Salix Pharmaceuticals Product
Table 91. Salix Pharmaceuticals Recent Development
Table 92. Sucampo Pharmaceuticals Corporation Information
Table 93. Sucampo Pharmaceuticals Description and Business Overview
Table 94. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Sucampo Pharmaceuticals Product
Table 96. Sucampo Pharmaceuticals Recent Development
Table 97. Ironwood Pharmaceuticals Corporation Information
Table 98. Ironwood Pharmaceuticals Description and Business Overview
Table 99. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Ironwood Pharmaceuticals Product
Table 101. Ironwood Pharmaceuticals Recent Development
Table 102. Progenics Pharmaceuticals Corporation Information
Table 103. Progenics Pharmaceuticals Description and Business Overview
Table 104. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Progenics Pharmaceuticals Product
Table 106. Progenics Pharmaceuticals Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Chronic Idiopathic Constipation (CIC) Drugs Customers List
Table 110. Chronic Idiopathic Constipation (CIC) Drugs Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Idiopathic Constipation (CIC) Drugs Product Picture
Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2017-2028 (K Units)
Figure 5. United States Chronic Idiopathic Constipation (CIC) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Chronic Idiopathic Constipation (CIC) Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Chronic Idiopathic Constipation (CIC) Drugs Sales 2017-2028 (K Units)
Figure 8. United States Chronic Idiopathic Constipation (CIC) Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Chronic Idiopathic Constipation (CIC) Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered
Figure 11. Product Picture of Lubiprostone
Figure 12. Product Picture of Linaclotide
Figure 13. Product Picture of Others
Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2022 & 2028
Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2017-2028) & (K Units)
Figure 18. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2022 & 2028
Figure 21. United States Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2017-2028) & (K Units)
Figure 24. United States Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Hospitals & Clinics
Figure 27. Product Picture of Ambulatory Surgical Centres
Figure 28. Product Picture of Long Term Care Centres
Figure 29. Product Picture of Others
Figure 30. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2017-2028) & (K Units)
Figure 34. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2017-2028) & (K Units)
Figure 40. United States Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Chronic Idiopathic Constipation (CIC) Drugs Value Chain
Figure 76. Chronic Idiopathic Constipation (CIC) Drugs Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed